Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 28, 2017; 23(4): 723-729
Published online Jan 28, 2017. doi: 10.3748/wjg.v23.i4.723
Published online Jan 28, 2017. doi: 10.3748/wjg.v23.i4.723
Table 2 Comparison of various outcomes achieved between the two groups n (%)
| Continuing group | Discontinuing group | χ2 | P value | |
| Recurrent ulcer bleeding events | 18 (18.4) | 4 (5.8) | 5.594 | 0.018 |
| Death or cardiovascular disease | 3 (3.1) | 15 (21.7) | 14.689 | 0.000 |
- Citation: Wang XX, Dong B, Hong B, Gong YQ, Wang W, Wang J, Zhou ZY, Jiang WJ. Long-term prognosis in patients continuing taking antithrombotics after peptic ulcer bleeding. World J Gastroenterol 2017; 23(4): 723-729
- URL: https://www.wjgnet.com/1007-9327/full/v23/i4/723.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i4.723